Tag: RBM strategy

Evidence Packages to Demonstrate RBM Execution and Oversight The evolution of clinical research demands innovative methodologies, particularly around risk-based monitoring (RBM) and remote oversight. Regulatory agencies such as the FDA, EMA, and MHRA are increasingly emphasizing the importance of robust documentation to support these practices. This article provides a comprehensive step-by-step guide aimed at clinical…

Read More “Evidence Packages to Demonstrate RBM Execution and Oversight” »

Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs Clinical trials are essential to the development of effective medical interventions. Their management requires adherence to strict regulations, particularly regarding documentation and monitoring of risk. As the industry evolves towards Risk-Based Monitoring (RBM), appropriate documentation related to…

Read More “Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs” »

Preparing RBM Methodology White Papers for Complex Programs Preparing RBM Methodology White Papers for Complex Programs Understanding Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) is an innovative approach to clinical trial management designed to improve the oversight of clinical research while ensuring compliance with regulatory standards. The methodology shifts the focus from traditional monitoring…

Read More “Preparing RBM Methodology White Papers for Complex Programs” »

Documenting RBM Strategy for Health Authorities: What to Include and Why In the context of clinical trials, especially those focused on ovarian cancer, ensuring compliance with regulatory requirements is a multifaceted process. Among the various strategies employed to enhance the efficiency of clinical trials, Risk-Based Monitoring (RBM) has emerged as a noteworthy approach. This step-by-step…

Read More “Documenting RBM Strategy for Health Authorities: What to Include and Why” »

Writing RBM Sections in Protocols, Clinical Study Reports and Briefing Packages Understanding Risk-Based Monitoring (RBM) in Clinical Trials Risk-Based Monitoring (RBM) has become a fundamental component in the clinical trial landscape, particularly for eisf clinical trials. This methodology diverges from traditional monitoring approaches by emphasizing the identification and management of risks rather than merely on-site…

Read More “Writing RBM Sections in Protocols, Clinical Study Reports and Briefing Packages” »